Expanding Psychedelic Medicine

Watch MAPS Founder Rick Doblin, Ph.D., present the first TED Talk on psychedelics to an audience in Vancouver, British Columbia.

Expanding Psychedelic Medicine

Make A Gift

We’re making evidence-based treatments for mental health conditions.

Press Releases

MDMA-Assisted Psychotherapy

Our highest priority project is funding clinical trials of 3,4-methylenedioxymethamphetamine (MDMA) as a tool to assist psychotherapy for the treatment of posttraumatic stress disorder (PTSD).

We have also sponsored clinical trials of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness, and for social anxiety in autistic adults, LSD-assisted psychotherapy for anxiety, and medical marijuana for PTSD in veterans of war. We have sponsored observational studies for ibogaine therapy for drug addiction and ayahuasca-assisted treatment for drug addiction and PTSD.

MDMA website

our education website

Our Education Programs

In addition to our clinical research programs, MAPS provides harm reduction training and services through the Zendo Project, advocates for reducing barriers to scientific research with psychedelics and marijuana, and curates educational events and webinars.

Our Values


Information is shared openly and clearly. Communications are respectful, honest, and forthright.

Passion and Perseverance

We persist in the face of challenges. We have a sense of urgency about our work, and know that it's a long-term effort.

Intelligent Risk

Our decisions are informed by research. We try new things and learn from our mistakes.

Trust and Accountability

We value integrity and honesty, and embrace high standards.